Novelion Therapeutics Inc. by Alvarez & Marsal Canada Inc., Novelion's liquidator (the “Liquidator”) announced the anticipated date of its final cash distribution to its registered shareholders (the “Final Distribution”) will be on or about March 31, 2022. The Final Distribution is comprised of approximately $2.47 million ($0.125 per share), representing the aggregate of the cash remaining in Novelion, including the proceeds from the sale of the remaining American depository receipts (ADRs) of Amryt Pharma plc, less the anticipated expenses through the completion of the Company's statutory liquidation. As with prior distributions, those shareholders who were registered shareholders of Novelion as of January 16, 2020, being the effective date of the Liquidation (the “Effective Date”), are entitled to their pro rata share of all distributions made in connection with Novelion's ongoing statutory liquidation and dissolution, including the Final Distribution.